Trader consensus at 97.9% against Jeffrey Epstein being confirmed alive before 2027 reflects the absence of any credible evidence challenging the official 2019 determination of death by suicide at the Metropolitan Correctional Center. Extensive official records, including autopsy findings, prison documentation, and a detailed 2026 New York Times investigation, point to institutional lapses enabling the suicide rather than any survival scenario. Ongoing congressional reviews of Epstein files and associates in 2026 have produced no sightings, leaks, or contradictory forensic data. With only months remaining until 2027, the short timeline further limits realistic pathways for a verified reappearance. Unlikely developments that could still shift odds include authenticated DNA evidence, official government confirmation of prior misidentification, or a high-profile emergence under witness protection protocols, though all lack supporting indicators.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$2,562,743 Vol.
$2,562,743 Vol.
$2,562,743 Vol.
$2,562,743 Vol.
The primary resolution source for this market will be a consensus of credible sources.
Market Opened: Dec 29, 2025, 4:53 PM ET
Resolver
0x65070BE91...The primary resolution source for this market will be a consensus of credible sources.
Resolver
0x65070BE91...Trader consensus at 97.9% against Jeffrey Epstein being confirmed alive before 2027 reflects the absence of any credible evidence challenging the official 2019 determination of death by suicide at the Metropolitan Correctional Center. Extensive official records, including autopsy findings, prison documentation, and a detailed 2026 New York Times investigation, point to institutional lapses enabling the suicide rather than any survival scenario. Ongoing congressional reviews of Epstein files and associates in 2026 have produced no sightings, leaks, or contradictory forensic data. With only months remaining until 2027, the short timeline further limits realistic pathways for a verified reappearance. Unlikely developments that could still shift odds include authenticated DNA evidence, official government confirmation of prior misidentification, or a high-profile emergence under witness protection protocols, though all lack supporting indicators.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions